|
1.Adams, P.D. (2001). Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471, M123-133.
2.Aggarwal, B.B., and Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421.
3.Altiok, S., Batt, D., Altiok, N., Papautsky, A., Downward, J., Roberts, T.M., and Avraham, H. (1999). Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells. J Biol Chem 274, 32274-32278.
4.Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A.S., Shishodia, S., and Aggarwal, B.B. (2007). Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302.
5.Blank, V.C., Pena, C., and Roguin, L.P. (2010). STAT1, STAT3 and p38MAPK are involved in the apoptotic effect induced by a chimeric cyclic interferon-alpha2b peptide. Exp Cell Res 316, 603-614.
6.Braakhuis, B.J., Tabor, M.P., Kummer, J.A., Leemans, C.R., and Brakenhoff, R.H. (2003). A genetic explanation of Slaughter''s concept of field cancerization: evidence and clinical implications. Cancer Res 63, 1727-1730.
7.Carson, J.P., Kulik, G., and Weber, M.J. (1999). Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3''-kinase and Akt/protein kinase B. Cancer Res 59, 1449-1453.
8.Chen, T., Wong, Y.S., and Zheng, W. (2009). Induction of G1 cell cycle arrest and mitochondria-mediated apoptosis in MCF-7 human breast carcinoma cells by selenium-enriched Spirulina extract. Biomed Pharmacother.
9.Delannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmels, T., Vercamer, C., Boilly, B., Vandenbunder, B., and Desbiens, X. (1998). The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111 ( Pt 11), 1521-1534.
10.Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev 12, 2245-2262.
11.Fan, E., Jiang, S., Zhang, L., and Bai, Y. (2008). Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent. Int J Vitam Nutr Res 78, 3-8.
12.Fang, F., Orend, G., Watanabe, N., Hunter, T., and Ruoslahti, E. (1996). Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271, 499-502.
13.Fox, G.L., Rebay, I., and Hynes, R.O. (1999). Expression of DFak56, a Drosophila homolog of vertebrate focal adhesion kinase, supports a role in cell migration in vivo. Proc Natl Acad Sci U S A 96, 14978-14983.
14.Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L.R., Neale, G., Zheng, J., et al. (2007). An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res 67, 573-579.
15.Galaktionov, K., and Beach, D. (1991). Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67, 1181-1194.
16.Gosslau, A., Chen, M., Ho, C.T., and Chen, K.Y. (2005). A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. Br J Cancer 92, 513-521.
17.Hildebrand, J.D., Schaller, M.D., and Parsons, J.T. (1993). Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 123, 993-1005.
18.Ho, A., and Dowdy, S.F. (2002). Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev 12, 47-52. Hsieh, T.C., and Wu, J.M. (2008). Suppression of cell proliferation and gene 19.expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol 33, 851-859.
20.Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
21.Johnson, G.L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
22.Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
23.Keenan, S.M., Bellone, C., and Baldassare, J.J. (2001). Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase. J Biol Chem 276, 22404-22409.
24.Kelly-Spratt, K.S., Philipp-Staheli, J., Gurley, K.E., Hoon-Kim, K., Knoblaugh, S., and Kemp, C.J. (2009). Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer. Oncogene 28, 3652-3662.
25.Kundu, J.K., and Surh, Y.J. (2008). Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269, 243-261.
26.Lavoie, J.N., L''Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271, 20608-20616.
27.Lents, N.H., Keenan, S.M., Bellone, C., and Baldassare, J.J. (2002). Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J Biol Chem 277, 47469-47475.
28.Liggett, W.H., Jr., and Sidransky, D. (1998). Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16, 1197-1206.
29.Lin, H.K., Yeh, S., Kang, H.Y., and Chang, C. (2001). Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci U S A 98, 7200-7205.
30.Lu, J., Ho, C.H., Ghai, G., and Chen, K.Y. (2001). Resveratrol analog, 3,4,5,4''-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 22, 321-328.
31.Luh, F.Y., Archer, S.J., Domaille, P.J., Smith, B.O., Owen, D., Brotherton, D.H., Raine, A.R., Xu, X., Brizuela, L., Brenner, S.L., et al. (1997). Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature 389, 999-1003.
32.MacGregor, J.I., and Jordan, V.C. (1998). Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50, 151-196.
33.Malumbres, M., and BaRbacid, M. (2005). Mammalian cyclin-dependent kinases. Trends Biochem Sci 30, 630-641.
34.Martin-Berenjeno, I., and Vanhaesebroeck, B. (2009). PI3K regulatory subunits lose control in cancer. Cancer Cell 16, 449-450.
35.McConnell, B.B., Gregory, F.J., Stott, F.J., Hara, E., and Peters, G. (1999). Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol 19, 1981-1989.
36.Ohi, R., and Gould, K.L. (1999). Regulating the onset of mitosis. Curr Opin Cell Biol 11, 267-273.
37.Pan, M.H., Gao, J.H., Lai, C.S., Wang, Y.J., Chen, W.M., Lo, C.Y., Wang, M., Dushenkov, S., and Ho, C.T. (2008). Antitumor activity of 3,5,4''-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice. Mol Carcinog 47, 184-196.
38.Price, J.E. (1986). Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. J Natl Cancer Inst 77, 529-535.
39.Riccardi, C., and Nicoletti, I. (2006). Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1, 1458-1461. 40.Rimando, A.M., Cuendet, M., Desmarchelier, C., Mehta, R.G., Pezzuto, J.M., and Duke, S.O. (2002). Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50, 3453-3457.
41.Rimando, A.M., Kalt, W., Magee, J.B., Dewey, J., and Ballington, J.R. (2004). Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52, 4713-4719.
42.Robinson, M.J., and Cobb, M.H. (1997). Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9, 180-186.
43.Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., KoopeRberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women''s Health Initiative randomized controlled trial. JAMA 288, 321-333.
44.Russo, A.A., Jeffrey, P.D., Patten, A.K., Massague, J., and Pavletich, N.P. (1996). Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
45.Ryan, K.M., Phillips, A.C., and Vousden, K.H. (2001). Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13, 332-337.
46.Sakamoto, T., Horiguchi, H., Oguma, E., and Kayama, F. (2009). Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen receptor positive breast cancer cells. J Nutr Biochem.
47.Scheid, M.P., and Woodgett, J.R. (2003). Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 546, 108-112.
48.Service, R.F. (1998). New role for estrogen in cancer? Science 279, 1631-1633. Shah, M.A., and Schwartz, G.K. (2003). Cyclin-dependent kinases as targets for cancer therapy. Cancer Chemother Biol Response Modif 21, 145-170.
49.Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.Sherr, C.J. (2000). The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60, 3689-3695. 50.Sherr, C.J., and Roberts, J.M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512.
51.Smith, M.L., and Fornace, A.J., Jr. (1996). Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mutat Res 340, 109-124.
52.Sommer, S., and Fuqua, S.A. (2001). Estrogen receptor and breast cancer. Semin Cancer Biol 11, 339-352.
53.Stevaux, O., and Dyson, N.J. (2002). A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 14, 684-691.
54.Tang, H.Y., Shih, A., Cao, H.J., Davis, F.B., Davis, P.J., and Lin, H.Y. (2006). Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5, 2034-2042.
55.Teranishi, S., Kimura, K., and Nishida, T. (2009). Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. Invest Ophthalmol Vis Sci 50, 5646-5652.
56.Tolomeo, M., Grimaudo, S., Di Cristina, A., Roberti, M., Pizzirani, D., Meli, M., Dusonchet, L., Gebbia, N., Abbadessa, V., Crosta, L., et al. (2005). Pterostilbene and 3''-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37, 1709-1726.
57.Wang, X., Flynn, A., Waskiewicz, A.J., Webb, B.L., Vries, R.G., Baines, I.A., Cooper, J.A., and Proud, C.G. (1998). The phosphorylation of eukaryotic initiation factor eIF4E in response to phoRbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273, 9373-9377.
58.Weston, C.R., and Davis, R.J. (2007). The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142-149.
59.Wilkinson, M.G., and Millar, J.B. (2000). Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J 14, 2147-2157.
60.Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704. 61.Zhang, W., and Liu, H.T. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12, 9-18.
|